Literature DB >> 28450849

Striatal and Hippocampal Atrophy in Idiopathic Parkinson's Disease Patients without Dementia: A Morphometric Analysis.

Jared J Tanner1, Nikolaus R McFarland2,3, Catherine C Price1.   

Abstract

BACKGROUND: Analyses of subcortical gray structure volumes in non-demented idiopathic Parkinson's disease (PD) often, but not always, show volume loss of the putamen, caudate nucleus, nucleus accumbens, and hippocampus. There is building evidence that structure morphometry might be more sensitive to disease-related processes than volume.
OBJECTIVE: To assess morphometric differences of subcortical structures (putamen, caudate nucleus, thalamus, globus pallidus, nucleus accumbens, and amygdala) as well as the hippocampus in non-demented individuals with PD relative to age and education matched non-PD peers.
METHODS: Prospective recruitment of idiopathic no-dementia PD and non-PD peers as part of a federally funded investigation. T1-weighted isovoxel metrics acquired via 3-T Siemens Verio for all individuals [PD n = 72 (left side onset n = 27, right side onset n = 45); non-PD n = 48]. FIRST (FMRIB Software Library) applications provided volumetric and vertex analyses on group differences for structure size and morphometry.
RESULTS: Group volume differences were observed only for putamen and hippocampi (PD < non-PD) with hippocampal volume significantly associating with disease duration. Group shape differences were observed for bilateral putamen, caudate nucleus, and hippocampus with greater striatal atrophy contralateral to side of motor symptom onset. Hippocampal shape differences disappeared when removing the effects of volume.
CONCLUSION: The putamen was the primary structure to show both volume and shape differences in PD, indicating that the putamen is the predominant site of basal ganglia atrophy in early- to mid-stage PD. Side of PD symptom onset associates with contralateral striatal atrophy. Left-onset PD might experience more extensive striatal atrophy than right-onset PD. Hippocampus morphometric results suggest possible primary atrophy of CA3/4 and dentate gyrus.

Entities:  

Keywords:  Parkinson’s disease; hippocampus; magnetic resonance imaging; morphometry; neostriatum

Year:  2017        PMID: 28450849      PMCID: PMC5389981          DOI: 10.3389/fneur.2017.00139

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  51 in total

1.  Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.

Authors:  Patrice Péran; Andrea Cherubini; Francesca Assogna; Fabrizio Piras; Carlo Quattrocchi; Antonella Peppe; Pierre Celsis; Olivier Rascol; Jean-François Démonet; Alessandro Stefani; Mariangela Pierantozzi; Francesco Ernesto Pontieri; Carlo Caltagirone; Gianfranco Spalletta; Umberto Sabatini
Journal:  Brain       Date:  2010-08-23       Impact factor: 13.501

Review 2.  MDS research criteria for prodromal Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Charles H Adler; Bastiaan R Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

3.  Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.

Authors:  Demetrio Messina; Antonio Cerasa; Francesca Condino; Gennarina Arabia; Fabiana Novellino; Giuseppe Nicoletti; Maria Salsone; Maurizio Morelli; Pier Luigi Lanza; Aldo Quattrone
Journal:  Parkinsonism Relat Disord       Date:  2011-01-13       Impact factor: 4.891

4.  Asymmetrical lateral ventricular enlargement in Parkinson's disease.

Authors:  M M Lewis; A B Smith; M Styner; H Gu; R Poole; H Zhu; Y Li; X Barbero; S Gouttard; M J McKeown; R B Mailman; X Huang
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

Review 5.  A critical reappraisal of current staging of Lewy-related pathology in human brain.

Authors:  Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2008-07-01       Impact factor: 17.088

6.  Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.

Authors:  Dao-Ying Geng; Yu-Xin Li; Chi-Shing Zee
Journal:  Neurosurgery       Date:  2006-02       Impact factor: 4.654

7.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

Authors:  M P Laakso; K Partanen; P Riekkinen; M Lehtovirta; E L Helkala; M Hallikainen; T Hanninen; P Vainio; H Soininen
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

8.  Comprehensive morphometry of subcortical grey matter structures in early-stage Parkinson's disease.

Authors:  Ricarda A L Menke; Konrad Szewczyk-Krolikowski; Saad Jbabdi; Mark Jenkinson; Kevin Talbot; Clare E Mackay; Michele Hu
Journal:  Hum Brain Mapp       Date:  2013-07-16       Impact factor: 5.038

9.  Reduced striatal volumes in Parkinson's disease: a magnetic resonance imaging study.

Authors:  Toni L Pitcher; Tracy R Melzer; Michael R Macaskill; Charlotte F Graham; Leslie Livingston; Ross J Keenan; Richard Watts; John C Dalrymple-Alford; Tim J Anderson
Journal:  Transl Neurodegener       Date:  2012-08-21       Impact factor: 8.014

10.  Shape (but not volume) changes in the thalami in Parkinson disease.

Authors:  Martin J McKeown; Ashish Uthama; Rafeef Abugharbieh; Samantha Palmer; Mechelle Lewis; Xuemei Huang
Journal:  BMC Neurol       Date:  2008-04-16       Impact factor: 2.474

View more
  13 in total

1.  Multimodal MRI evaluation of parkinsonian limbic pathologies.

Authors:  Ernest W Wang; Guangwei Du; Mechelle M Lewis; Eun-Young Lee; Sol De Jesus; Sangam Kanekar; Lan Kong; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2019-01-16       Impact factor: 4.673

2.  Subcortical amyloid load is associated with shape and volume in cognitively normal individuals.

Authors:  Shady Rahayel; Christian Bocti; Pénélope Sévigny Dupont; Maude Joannette; Marie Maxime Lavallée; Jim Nikelski; Howard Chertkow; Sven Joubert
Journal:  Hum Brain Mapp       Date:  2019-05-30       Impact factor: 5.038

3.  Common neurodegenerative disorders in the perioperative setting: Recommendations for screening from the Society for Perioperative Assessment and Quality Improvement (SPAQI).

Authors:  Margaret Wiggins; Franchesca Arias; Richard D Urman; Deborah C Richman; Bobbie Jean Sweitzer; Angela F Edwards; Melissa J Armstrong; Anita Chopra; David J Libon; Catherine Price
Journal:  Perioper Care Oper Room Manag       Date:  2020-02-05

Review 4.  Nucleus accumbens atrophy in Parkinson's disease (Mavridis' atrophy): 10 years later.

Authors:  Ioannis N Mavridis; Efstratios-Stylianos Pyrgelis
Journal:  Am J Neurodegener Dis       Date:  2022-06-20

5.  Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons.

Authors:  Samuel J Crowley; Guita Banan; Manish Amin; Jared J Tanner; Loren Hizel; Peter Nguyen; Babette Brumback; Katie Rodriguez; Nikolaus McFarland; Dawn Bowers; Mingzhou Ding; Thomas A Mareci; Catherine C Price
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

6.  A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.

Authors:  Laura Louise Scott; Timothy Grant Downing
Journal:  Toxins (Basel)       Date:  2017-12-29       Impact factor: 4.546

7.  Cognition and connectomes in nondementia idiopathic Parkinson's disease.

Authors:  Luis M Colon-Perez; Jared J Tanner; Michelle Couret; Shelby Goicochea; Thomas H Mareci; Catherine C Price
Journal:  Netw Neurosci       Date:  2018-03-01

8.  Automated Subfield Volumetric Analysis of Hippocampus in Patients with Drug-Naïve Nondementia Parkinson's Disease.

Authors:  Jin-Woo Park; Chan-Nyoung Lee; Youngbo Sim; Hyung-Kyu Ham; Woo-Suk Tae; Byung-Jo Kim
Journal:  Parkinsons Dis       Date:  2019-02-03

9.  [18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease.

Authors:  Adam J Stark; Christopher T Smith; Kalen J Petersen; Paula Trujillo; Nelleke C van Wouwe; Manus J Donahue; Robert M Kessler; Ariel Y Deutch; David H Zald; Daniel O Claassen
Journal:  Neuroimage Clin       Date:  2018-02-10       Impact factor: 4.881

10.  Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's disease.

Authors:  Christian La; Patricia Linortner; Jeffrey D Bernstein; Matthew A I Ua Cruadhlaoich; Michelle Fenesy; Gayle K Deutsch; Brian K Rutt; Lu Tian; Anthony D Wagner; Michael Zeineh; Geoffrey A Kerchner; Kathleen L Poston
Journal:  Neuroimage Clin       Date:  2019-04-18       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.